NASDAQ · FATE

Fate Therapeutics Inc

Smart money pulse

What insiders and funds are doing

Selling Insiders: as of Nov 12 Funds: as of Jun 30, 2026
−1000+100 −45
  • account_balance
    85 funds bought, 69 sold in the quarter ended Jun 30, 2026. 32 were new holders.
  • info
    1 real insider sale in 12 months. $13.5K in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

155 funds report owning FATE, down from 157

Holdings as of Jun 30, 2026
New32
Added53
Held35
Trimmed35
Sold out34

Last quarter

Who bought and who sold

Change in shares held, biggest holdings first. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovOpen-market sale · Nov 3 · $13.5K
CEOCFOOther officersDirectorsJunJulAugSepOctNovOpen-market sale · Nov 3 · $13.5K

Last 6 months. A wider screen shows 12.

Showing 1 real trade. Bigger dot means a bigger trade.

Real trades, newest first

Nov 3 Kamal Adawi CFO Open-market sale $13.5K 6,582 sh at $2.05

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in FATE

As of Jun 30, 2026

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K).

This is data, not investment advice. About StockToast